Page last updated: 2024-08-21

diphenylamine and casein kinase ii

diphenylamine has been researched along with casein kinase ii in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bian, Y; Chen, Z; Cheng, H; Friedman, J; Han, J; Kannabiran, V; Mohan, S; VanWaes, C; Zhang, L1
Chaney, KE; Kendall, JJ; Largaespada, DA; Patel, AV; Ratner, N; Rizvi, TA1

Other Studies

2 other study(ies) available for diphenylamine and casein kinase ii

ArticleYear
MEK inhibitor PD-0325901 overcomes resistance to CK2 inhibitor CX-4945 and exhibits anti-tumor activity in head and neck cancer.
    International journal of biological sciences, 2015, Volume: 11, Issue:4

    Topics: Animals; Benzamides; Blotting, Western; Casein Kinase II; Cell Line, Tumor; Diphenylamine; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Inbred BALB C; Mice, SCID; Naphthyridines; NF-kappa B; Phenazines; Proto-Oncogene Proteins c-fos; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2015
CK2 blockade causes MPNST cell apoptosis and promotes degradation of β-catenin.
    Oncotarget, 2016, Aug-16, Volume: 7, Issue:33

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; beta Catenin; Casein Kinase II; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Diphenylamine; Drug Synergism; Female; Humans; Mice, Nude; Naphthyridines; Nerve Sheath Neoplasms; Phenazines; Proteolysis; RNA Interference; Xenograft Model Antitumor Assays

2016